Complications of gastric bypass: diagnosis and treatment
May 1, 2021 10:10am ‐ May 1, 2021 10:35am
Identification: 15.2
Presentation style: Case-based session with panel
- Understand commonly observed complications after gastric bypass surgery
- Define medical, endoscopic, and surgical management options for complications after gastric bypass surgery
- Describe gastric bypass anatomy and its impact on the endoscopic approach to complications
Indeterminate biliary strictures: Not so indeterminate anymore?
May 1, 2021 10:10am ‐ May 1, 2021 10:35am
Identification: 17.2
Presentation style: Case-based session with panel
- Understand the definition and significance of indeterminate biliary stricture
- Compare and contrast available diagnostic options for biliary strictures
- Recognize the importance of multi-modality sampling of biliary strictures
Gastroparesis: diet, medication, bypass or myotomy?
May 1, 2021 10:35am ‐ May 1, 2021 10:55am
Identification: 15.3
Presentation style: Interview
- Appreciate currently available medical therapies for the treatment of gastroparesis
- Evaluate data supporting the use of gastric bypass in patients with gastroparesis
- Review recent data on the use of G-POEM to treat refractory gastroparesis symptoms.
Pancreatic Cystic lesions: Changing our Approach
May 1, 2021 10:35am ‐ May 1, 2021 10:55am
Identification: 17.3
Presentation style: Interview
- Describe recent advances in pancreatic cyst fluid analysis, including next generation sequencing and fluid glucose
- Assess the role of intraprocedural diagnostic techniques, such as EUS-directed microforceps biopsy and needle-based confocal laser endomicroscopy
- Recognize novel modalities for the endoscopic treatment of pancreatic cysts
Product Theater: Eosinophilic Esophagitis: An Expert’s view on the implications of Type 2 Inflammation
May 1, 2021 11:15am ‐ May 1, 2021 11:45am
Identification: 97
Faculty:
Ikuo Hirano, MD
Professor of Medicine|Feinberg School of Medicine|Northwestern University
Description: Learn the importance of identifying Type 2 inflammation in your patients with EoE. In this virtual event, our expert will discuss how underlying Type 2 inflammation has local manifestations in the esophagus and describe the coexisting nature of Type 2 diseases in patients with EoE.
New Concepts in Cirrhosis Management
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.1
Learning Objectives:
- Determine the latest in HCC therapeutics
- Understand newer diagnostic and prognostic models of acute on chronic liver failure
- Understand the role of gut microbiota in cirrhosis